RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia.
作者信息
Chow Signy, Tang Kenny, Al-Abri Mahmood, Hall Victoria, Tremblay-Lemay Rosemarie, Rashedi Iran, Tsui Hubert, Chan Steven M
机构信息
Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada.
Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Canada.
出版信息
Leuk Res. 2021 Dec;111:106735. doi: 10.1016/j.leukres.2021.106735. Epub 2021 Oct 23.
Abstract
摘要
Zotero 插件